Examining The Quality Oversight Of Car T Clinical Manufacturing And The Challenges Of Moving Into Commercial Operations

  • Discussing quality considerations in the CAR T-cell immunotherapies supply chain
  • Understanding facility and testing requirements
  • Quality and manufacturing considerations for the vector supplier
  • Navigating supply chain logistics of getting in and out of countries and maintaining chain of custody
  • Regulatory and quality requirements of the FDA and other agencies

Leave a reply

Please enter your comment!
Please enter your name here